These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 34750691

  • 21. High levels of platelet-to-lymphocyte ratio may predict reduced risk of end stage of renal disease in Chinese patients with MPO-ANCA associated vasculitis.
    Huang L, Shen C, Zhong Y, Ooi JD, Eggenhuizen PJ, Zhou Y, Chen J, Wu T, Meng T, Xiao Z, Lin W, Tang R, Ao X, Xiao X, Zhou Q, Xiao P.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb 28; 47(2):211-218. PubMed ID: 35545411
    [Abstract] [Full Text] [Related]

  • 22. Multivariable index for assessing the activity and predicting all-cause mortality in antineutrophil cytoplasmic antibody-associated vasculitis.
    Kim MK, Choi H, Kim JY, Song JJ, Park YB, Lee SW.
    J Clin Lab Anal; 2020 Jan 28; 34(1):e23022. PubMed ID: 31441120
    [Abstract] [Full Text] [Related]

  • 23. The novel fibrosis index at diagnosis may predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis without substantial liver diseases.
    Pyo JY, Ahn SS, Lee LE, Choi GM, Song JJ, Park YB, Lee SW.
    Clinics (Sao Paulo); 2021 Jan 28; 76():e2501. PubMed ID: 33852653
    [Abstract] [Full Text] [Related]

  • 24. Tubulointerstitial damage and interstitial immune cell phenotypes are useful predictors for renal survival and relapse in antineutrophil cytoplasmic antibody-associated vasculitis.
    Bitton L, Vandenbussche C, Wayolle N, Gibier JB, Cordonnier C, Verine J, Humez S, Bataille P, Lenain R, Ramdane N, Azar R, Mac Namara E, Hatron PY, Maurage CA, Perrais M, Frimat M, Vanhille P, Glowacki F, Buob D, Copin MC, Quéméneur T, Gnemmi V.
    J Nephrol; 2020 Aug 28; 33(4):771-781. PubMed ID: 31916228
    [Abstract] [Full Text] [Related]

  • 25. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM, Choi SY, Kim SY, Kim J.
    Rheumatol Int; 2019 Nov 28; 39(11):1919-1926. PubMed ID: 31552433
    [Abstract] [Full Text] [Related]

  • 26. Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.
    Sada KE, Harigai M, Amano K, Atsumi T, Fujimoto S, Yuzawa Y, Takasaki Y, Banno S, Sugihara T, Kobayashi M, Usui J, Yamagata K, Homma S, Dobashi H, Tsuboi N, Ishizu A, Sugiyama H, Okada Y, Arimura Y, Matsuo S, Makino H, for Research Committee of Intractable Vasculitis Syndrome and Research Committee of Intractable Renal Disease of the Ministry of Health, Labour, and Welfare of Japan.
    Mod Rheumatol; 2016 Sep 28; 26(5):730-7. PubMed ID: 26873424
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Systemic inflammation response index predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Lee LE, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW.
    Int Urol Nephrol; 2021 Aug 28; 53(8):1631-1638. PubMed ID: 33428165
    [Abstract] [Full Text] [Related]

  • 31. Fibrinogen to albumin ratio reflects the activity of antineutrophil cytoplasmic antibody-associated vasculitis.
    Lee LE, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW.
    J Clin Lab Anal; 2021 Apr 28; 35(4):e23731. PubMed ID: 33591581
    [Abstract] [Full Text] [Related]

  • 32. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study.
    Sacri AS, Chambaraud T, Ranchin B, Florkin B, Sée H, Decramer S, Flodrops H, Ulinski T, Allain-Launay E, Boyer O, Dunand O, Fischbach M, Hachulla E, Pietrement C, Le Pogamp P, Stephan JL, Belot A, Nivet H, Nobili F, Guillevin L, Quartier P, Deschênes G, Salomon R, Essig M, Harambat J.
    Nephrol Dial Transplant; 2015 Apr 28; 30 Suppl 1():i104-12. PubMed ID: 25676121
    [Abstract] [Full Text] [Related]

  • 33. Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naïve patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Kim Y, Choi H, Jung SM, Song JJ, Park YB, Lee SW.
    Nephrology (Carlton); 2019 Jul 28; 24(7):711-717. PubMed ID: 30203901
    [Abstract] [Full Text] [Related]

  • 34. Novel mortality-predicting index at diagnosis can effectively predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Do H, Song JJ, Park YB, Lee SW.
    J Clin Lab Anal; 2021 Aug 28; 35(8):e23885. PubMed ID: 34181278
    [Abstract] [Full Text] [Related]

  • 35. Correlation between serum cysteine-rich protein 61 and disease activity of antineutrophil cytoplasmic antibody-associated vasculitis.
    Yoon T, Ahn SS, Pyo JY, Lee LE, Song JJ, Park YB, Lee SW.
    Clin Rheumatol; 2021 Sep 28; 40(9):3703-3710. PubMed ID: 33755835
    [Abstract] [Full Text] [Related]

  • 36. Serum Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein-1 Can Predict Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Pilot Monocentric Study.
    Ahn SS, Kim JO, Yoon T, Song JJ, Park YB, Lee SW, Park SG.
    Biomed Res Int; 2019 Sep 28; 2019():7508240. PubMed ID: 31236412
    [Abstract] [Full Text] [Related]

  • 37. Antibody subtypes and titers predict clinical outcomes in ANCA-associated vasculitis.
    Aljuhani M, Makati D, Hoff A, Thompson J, Pellegrino B, Shawwa K, Schmidt R, Kannabhiran D.
    Rheumatol Int; 2021 May 28; 41(5):965-972. PubMed ID: 33585954
    [Abstract] [Full Text] [Related]

  • 38. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
    Lin W, Shen C, Zhong Y, Ooi JD, Eggenhuizen P, Zhou YO, Luo H, Huang J, Chen JB, Wu T, Meng T, Xiao Z, Ao X, Peng W, Tang R, Yin H, Xiao X, Zhou Q, Xiao P.
    Front Immunol; 2021 May 28; 12():625672. PubMed ID: 33841408
    [Abstract] [Full Text] [Related]

  • 39. Trends in Long-Term Outcomes Among Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Disease.
    Rhee RL, Hogan SL, Poulton CJ, McGregor JA, Landis JR, Falk RJ, Merkel PA.
    Arthritis Rheumatol; 2016 Jul 28; 68(7):1711-20. PubMed ID: 26814428
    [Abstract] [Full Text] [Related]

  • 40. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.
    Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, Nachman PH, Jennette JC, Falk RJ.
    Arthritis Rheum; 2012 Oct 28; 64(10):3452-62. PubMed ID: 23023777
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.